NYSE
UAMY
Last Price
US $6.45
KEY FIGURES
MKT CAP
$1.0B
EPS
TTM
$-0.11
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
23.39x
YIELD
0.00%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
United States Antimony Corporation cash flow to debt ratio of -5.24K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
United States Antimony Corporation's free cash flow has decreased -2.20K% from $1.79M last year to $-37.50M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
United States Antimony Corporation's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
United States Antimony Corporation's debt has decreased relative to shareholder equity from 0.06 last year to 0.00 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
United States Antimony Corporation has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
United States Antimony Corporation earns at least as much interest as it pays. Interest obligations are fully covered.
Financial risk - Profit margin growth.
United States Antimony Corporation's profit margin has decreased (257.77%) in the last year from -11.58% to -41.44%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
United States Antimony Corporation's short-term assets of $54.74M exceed its short-term liabilities of $10.18M
Decreasing performance - ROA.
United States Antimony Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
United States Antimony Corporation's return on equity of -16.94%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
United States Antimony Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
United States Antimony Corporation had positive net income in only 1.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
United States Antimony Corporation has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
United States Antimony Corporation has negative free cash flow, indicating cash burn
Decreasing performance - Healthy earnings growth.
United States Antimony Corporation's yearly earnings has decreased 150.78% since last year from $-1.73M to $-4.34M, signaling decreasing performance
Increasing performance - Healthy revenue growth.
United States Antimony Corporation's yearly revenue has increased 162.80% since last year from $14.94M to $39.26M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -12.11% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
United States Antimony Corporation's 3-year revenue CAGR of 52.61% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
United States Antimony Corporation had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
United States Antimony Corporation had positive ROE in only 1.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
United States Antimony Corporation has insufficient data to evaluate this check.
Overvalued - Earnings yield.
United States Antimony Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
United States Antimony Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
United States Antimony Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
United States Antimony Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - P/B ratio.
United States Antimony Corporation has a price-to-book ratio of 6.93x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Overvalued - P/S ratio.
United States Antimony Corporation has a price-to-sales ratio of 23.39x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
-16.94%
Return on equity
ROIC: -12.11%
Valuation History
-53.6X
Price to Earnings
EV/EBITDA: -51.8X
Cash flow
Profit margin
49.62%
(FY vs FY)
EBITDA Y/Y
-5.09%
(FY vs FY)
Cash flow Y/Y
-47.13%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $6.45
—
Default assumptions
EBITDA Multiple
Fair Value
Market $6.45
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.